Rare diseases
Investigational molecules
Locations
Back to Italy153 clinical trials in Messina, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)ItalyBI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases
ItalyStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
ItalyStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
ItalyStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
ItalyStudy on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis
ItalyStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
ItalyStudy on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet
ItalyStudy on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis
ItalyStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
ItalyStudy on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)
ItalyA Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on hematologic malignancies and solid tumors, including studies on chronic myeloid leukemia, multiple myeloma, and lung cancer treatments.
Research emphasizes targeted therapies and immunotherapy combinations for improved patient outcomes.
Clinical studies investigating treatments for Crohn's disease, ulcerative colitis, and pyoderma gangrenosum, focusing on novel therapeutic approaches.
Emphasis on developing targeted biological therapies for chronic inflammatory conditions.
Groundbreaking research on Rett Syndrome, transthyretin amyloidosis, and polycystic kidney disease, exploring innovative treatment options.
Focus on developing targeted treatments for rare genetic conditions and improving patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
